SBRA has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
SBRA has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Sabra Health Care REIT's Enterprise Value is $6,492.8 Mil. Sabra Health Care REIT's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was $243.0 Mil. Therefore, Sabra Health Care REIT's EV-to-EBIT ratio for today is 26.72.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Sabra Health Care REIT's Enterprise Value is $6,492.8 Mil. Sabra Health Care REIT's EBITDA for the trailing twelve months (TTM) ended in Dec. 2024 was $412.6 Mil. Therefore, Sabra Health Care REIT's EV-to-EBITDA ratio for today is 15.74.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Sabra Health Care REIT's Enterprise Value is $6,492.8 Mil. Sabra Health Care REIT's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 was $703.2 Mil. Therefore, Sabra Health Care REIT's EV-to-Revenue ratio for today is 9.23.
EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, Sabra Health Care REIT's Enterprise Value is $6,492.8 Mil. Sabra Health Care REIT's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 was $310.5 Mil. Therefore, Sabra Health Care REIT's EV-to-FCF ratio for today is 20.91.
The historical data trend for Sabra Health Care REIT's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sabra Health Care REIT Annual Data | |||||||||||||||||||||
Trend | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | Dec24 | |||||||||||
Enterprise Value | Get a 7-Day Free Trial |
![]() |
![]() |
6,028.47 | 5,451.79 | 5,371.15 | 5,705.52 | 6,499.03 |
Sabra Health Care REIT Quarterly Data | ||||||||||||||||||||
Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | Dec24 | |
Enterprise Value | Get a 7-Day Free Trial |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
5,705.52 | 5,853.74 | 6,047.55 | 6,838.36 | 6,499.03 |
For the REIT - Healthcare Facilities subindustry, Sabra Health Care REIT's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the REITs industry and Real Estate sector, Sabra Health Care REIT's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Sabra Health Care REIT's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Sabra Health Care REIT's Enterprise Value for the fiscal year that ended in Dec. 2024 is calculated as
Enterprise Value (A: Dec. 2024 ) | |||||
= | Market Cap | + | Preferred Stock | + | Long-Term Debt & Capital Lease Obligation |
= | 4115.00684 | + | 0 | + | 2337.941 |
+ | Short-Term Debt & Capital Lease Obligation | + | Minority Interest | - | Cash, Cash Equivalents, Marketable Securities |
+ | 106.554 | + | 0 | - | 60.468 |
= | 6,499.0 |
Sabra Health Care REIT's Enterprise Value for the quarter that ended in Dec. 2024 is calculated as
Enterprise Value (Q: Dec. 2024 ) | |||||
= | Market Cap | + | Preferred Stock | + | Long-Term Debt & Capital Lease Obligation |
= | 4115.00684 | + | 0 | + | 2337.941 |
+ | Short-Term Debt & Capital Lease Obligation | + | Minority Interest | - | Cash, Cash Equivalents, Marketable Securities |
+ | 106.554 | + | 0 | - | 60.468 |
= | 6,499.0 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sabra Health Care REIT (NAS:SBRA) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Sabra Health Care REIT's EV-to-EBIT for today is
EV-to-EBIT | = | Enterprise Value (Today) | / | EBIT (TTM) |
= | 6492.750 | / | 242.989 | |
= | 26.72 |
Sabra Health Care REIT's current Enterprise Value is $6,492.8 Mil.
Sabra Health Care REIT's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $243.0 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Sabra Health Care REIT's EV-to-EBITDA for today is:
EV-to-EBITDA | = | Enterprise Value (Today) | / | EBITDA(TTM) |
= | 6492.750 | / | 412.612 | |
= | 15.74 |
Sabra Health Care REIT's current Enterprise Value is $6,492.8 Mil.
Sabra Health Care REIT's EBITDA for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $412.6 Mil.
3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.
Sabra Health Care REIT's EV-to-Revenue for today is:
EV-to-Revenue | = | Enterprise Value (Today) | / | Revenue (TTM) |
= | 6492.750 | / | 703.235 | |
= | 9.23 |
Sabra Health Care REIT's current Enterprise Value is $6,492.8 Mil.
Sabra Health Care REIT's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $703.2 Mil.
4. EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow.
Sabra Health Care REIT's EV-to-FCF for today is:
EV-to-FCF | = | Enterprise Value (Today) | / | Free Cash Flow (TTM) |
= | 6492.750 | / | 310.541 | |
= | 20.91 |
Sabra Health Care REIT's current Enterprise Value is $6,492.8 Mil.
Sabra Health Care REIT's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $310.5 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Sabra Health Care REIT's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Catherine Cusack | director | 18500 VON KARMAN AVENUE, SUITE 550, IRVINE CA 92612 |
Michael J Foster | director | 36 GROVE STREET, NEW CANAAN CT 06840 |
Michael Lourenco Costa | officer: Executive VP & CAO | 18500 VON KARMAN AVENUE, SUITE 550, IRVINE CA 92612 |
Andrews Harold W. Jr. | officer: Executive VP, CFO & Secretary | C/O SABRA HEALTH CARE REIT, INC., 18500 VON KARMAN, SUITE 550, IRVINE CA 92612 |
Ann Kono | director | 18500 VON KARMAN AVENUE, SUITE 550, IRVINE CA 92612 |
Porter Clifton J Ii | director | 18500 VON KARMAN AVENUE, SUITE 550, IRVINE CA 92612 |
Robert A. Ettl | director | C/O SABRA HEALTH CARE REIT, INC., 18500 VON KARMAN, SUITE 550, IRVINE CA 92612 |
Richard K Matros | director, officer: CEO and President | |
Raymond J Lewis | director | 191 NORTH WACKER DRIVE, SUITE 1200, CHICAGO IL 60606 |
Lynne S Katzmann | director | 18500 VON KARMAN AVENUE,SUITE 550, IRVINE CA 92612 |
Milton J Walters | director | C/O SABRA HEALTH CARE REIT, INC., 18500 VON KARMAN AVENUE, SUITE 550, IRVINE CA 92612 |
Ronald G Geary | director | 10140 LINN STATION RD, LOUISVILLE KY 40223-3813 |
Jeffrey A. Malehorn | director | 191 NORTH WACKER DRIVE, SUITE 1200, CHICAGO IL 60606 |
Talya Nevo-hacohen | officer: Executive VP, CIO & Treasurer | C/O SABRA HEALTH CARE REIT, INC., 18500 VON KARMAN, SUITE 550, IRVINE CA 92612 |
Craig A. Barbarosh | director | 3525 PIEDMONT RD., NE, BUILDING 6, SUITE 700, ATLANTA GA 30305 |
From GuruFocus
By GuruFocus News • 02-03-2025
By GuruFocus News • 11-02-2024
By Business Wire • 08-07-2024
By Business Wire • 02-03-2025
By Business Wire • 10-31-2024
By GuruFocus News • 10-09-2024
By Business Wire • 10-21-2024
By Business Wire • 09-09-2024
By GuruFocus News • 11-04-2024
By GuruFocus News • 11-13-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.